Towards Healthcare
Diabetes Drugs Market Size to Skyrocket USD 143.76 Billion by 2035

Diabetes Drugs Market Expands with GLP-1 and Insulin Advances

According to market projections, the diabetes drugs sector is expected to grow from USD 75.16 billion in 2025 to USD 143.76 billion by 2035, reflecting a CAGR of 6.7%. The diabetes drugs market is growing due to the rising global prevalence of diabetes, with over 537 million adults affected. Factors driving this growth include increased R&D, government policies, public-private partnerships, and technological advancements. More than 75% of diabetics live in low- or middle-income countries.

Last Updated : 26 December 2025 Category: Therapeutic Area Insight Code: 5055 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Diabetes Drugs Market Assessment

  • Overview
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies
  • Global Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Diabetes Drugs Market Assessment

  • Overview
  • North America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • North America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • North America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • North America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Europe Diabetes Drugs Market Assessment

  • Overview
  • Europe Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Europe Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Europe Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Europe Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Asia-Pacific Diabetes Drugs Market Assessment

  • Overview
  • Asia-Pacific Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Asia-Pacific Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Asia-Pacific Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Asia-Pacific Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Latin America Diabetes Drugs Market Assessment

  • Overview
  • Latin America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Latin America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Latin America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Latin America Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Middle East and Africa Diabetes Drugs Market Assessment

  • Overview
  • Middle East and Africa Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Insulin
    • DPP- 4 Inhibitors
    • GLP-1 Receptor Agonists
    • SGLT2 Inhibitors
  • Middle East and Africa Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Diabetes Type (2021 – 2033)
    • Type 1
    • Type 2
  • Middle East and Africa Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Subcutaneous
    • Intravenous
  • Middle East and Africa Diabetes Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Online Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies

Company Profiles

  • Novo Nordisk A/s
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Sanofi
  • Merck & Co, Inc
  • Eli Lilly and Company
  • AstraZeneca
  • Takeda Pharmaceuticals Company Limited
  • Boehringer Ingelheim International GmbH 
  • Novartis AG
  • Johnson & Johnson Services, Inc.
  • Bayer AG

Conclusion & Recommendations

FAQ's

Answer : The global diabetes drugs market is valued at USD 75.16 billion in 2025 and is projected to reach USD 143.76 billion by 2035, growing at a CAGR of 6.7% driven by rising diabetes prevalence and patient support.

Answer : North America dominates the diabetes drugs market due to high diabetes prevalence, advanced healthcare infrastructure, favorable reimbursement policies, and strong pharmaceutical innovation.

Answer : Hospital pharmacies lead distribution due to higher patient footfall, physician-guided prescriptions, reimbursement benefits, and access to trained healthcare professionals.

Answer : U.S. Department of Health & Human Services, International Diabetes Federation, and World health Organization
Any Questions

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar